Replimune Group Gestion
Gestion contrôle des critères 2/4
Le PDG Replimune Group est Sush Patel, nommé en Apr2024, a un mandat de moins d'un an. détient directement 0.074% des actions de la société, d'une valeur de $ 599.12K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.2 ans et 6.4 ans.
Informations clés
Sush Patel
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.07% |
| Durée moyenne d'occupation des postes de direction | 1.2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 6.4yrs |
Mises à jour récentes de la gestion
Recent updates
Replimune: Strong Data In A Highly Differentiated Space
Sep 03Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16
Replimune: Continuing To Justify The Bear Thesis (For Now)
May 22Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer
Jan 23Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)
Dec 25Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Jan 06Replimune secures $200M term loan
Oct 07Replimune: Recent Developments Strengthen Bull Thesis
Aug 12Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Replimune Group GAAP EPS of -$0.78 misses by $0.15
Aug 04Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jun 24We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate
Apr 04Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth
Dec 16Replimune: In The 'Buy Zone' Again
Oct 01Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Sep 02Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business
May 24Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic
Apr 30We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow
Feb 08Replimune Group EPS misses by $0.03
Feb 04Dosing underway in Replimune's early-stage cancer study with gene therapy
Jan 05Replimune: Interesting Developer Of Oncolytic Immunotherapies
Dec 06Replimune Group EPS misses by $0.02
Nov 05Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$220m |
| Mar 31 2024 | n/a | n/a | -US$216m |
| Dec 31 2023 | n/a | n/a | -US$210m |
| Sep 30 2023 | n/a | n/a | -US$199m |
| Jun 30 2023 | n/a | n/a | -US$182m |
| Mar 31 2023 | US$3m | US$447k | -US$174m |
| Dec 31 2022 | n/a | n/a | -US$157m |
| Sep 30 2022 | n/a | n/a | -US$147m |
| Jun 30 2022 | n/a | n/a | -US$133m |
| Mar 31 2022 | US$7m | US$394k | -US$118m |
Rémunération vs marché: Données insuffisantes pour établir si la rémunération totale de Sush est raisonnable par rapport à des entreprises de taille similaire sur le marché US.
Rémunération et revenus: La rémunération de Sush a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Sush Patel (53 yo)
less than a year
Titularisation
US$2,595,003
Compensation
Dr. Sushil Patel, also known as Sush,Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and ser...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | US$6.02m | 1.87% $ 15.2m | |
| Chief Financial Officer | 1.2yrs | US$3.61m | 0.017% $ 141.5k | |
| Chief Medical Officer | 1.9yrs | US$2.45m | 0.017% $ 135.0k | |
| CEO & Director | less than a year | US$2.60m | 0.074% $ 599.1k | |
| Founder | no data | US$5.72m | 2.57% $ 20.9m | |
| Chief Accounting Officer & Treasurer | 1.5yrs | pas de données | 0.010% $ 83.5k | |
| Chief Commercial Officer | 1.9yrs | pas de données | 0.017% $ 141.6k | |
| Chief Manufacturing Officer & Framingham Site Head | less than a year | pas de données | pas de données |
1.2yrs
Durée moyenne de l'emploi
53yo
Âge moyen
Gestion expérimentée: L'équipe de direction de REPL n'est pas considérée comme expérimentée (ancienneté moyenne 1.2 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | US$6.02m | 1.87% $ 15.2m | |
| CEO & Director | less than a year | US$2.60m | 0.074% $ 599.1k | |
| Founder | 9.8yrs | US$5.72m | 2.57% $ 20.9m | |
| Independent Director | 7.1yrs | US$362.60k | 0.0098% $ 79.4k | |
| Independent Non-Executive Director | 6.5yrs | US$355.10k | 0% $ 0 | |
| Independent Director | 4.6yrs | US$360.10k | 0% $ 0 | |
| Director | less than a year | pas de données | pas de données | |
| Independent Director | 7.3yrs | US$357.60k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$352.60k | 0% $ 0 | |
| Lead Independent Director | 6.4yrs | US$516.81k | 0% $ 0 | |
| Independent Director | 1.4yrs | US$667.97k | 0% $ 0 |
6.4yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de REPL sont considérés comme expérimentés (ancienneté moyenne 6.4 ans).